CD4 and type 2 diabetes mellitus: Patients identified as having liver fibrosis were older (median (IQR) years; 52 (45 to 58) vs. 43 (34 to 51); p = 0.0001); were more likely to have a CD4+ T‐lymphocyte count <200 cells/mm3 (12% vs. 4%; p = 0.022), type 2 diabetes (21% vs. 7%; p = 0.003) and hypertension (44% vs. 26%; p = 0.035) when compared to those without fibrosis.